动物感染疾病诊断市场规模、份额和成长分析（按感染类型、技术、动物类型、最终用户和地区）- 产业预测，2025-2032 年

2023 年动物感染疾病诊断市场规模价值 20 亿美元，预计将从 2024 年的 21.8 亿美元成长到 2032 年的 43.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.0%。

动物感染疾病诊断市场对于快速且准确地识别动物感染疾病至关重要，从而改善健康结果并加强疾病控制。由于全球化、气候变迁和农业方法演变的影响，人畜共通感染疾病呈上升趋势，推动了市场的成长。然而，诊断成本高、发展中地区治疗机会有限以及熟练专业人员短缺等挑战可能会阻碍市场扩张。持续的研究和开发对于开发灵敏且特异性的诊断工具至关重要。儘管存在这些障碍，但透过快速和即时检测等技术创新仍然充满了机会。人们对通用感染疾病和「同一个健康」模式的认识不断提高，进一步推动了这个市场的发展，巩固了其在全球动物和公共卫生管理中的关键作用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

动物感染疾病诊断市场规模（依感染类型及复合年增长率）（2025-2032）

• 市场概况
• 细菌感染疾病
• 病毒感染
• 寄生虫感染疾病
• 其他感染疾病

动物感染疾病诊断市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 免疫诊断
  • 横向流动化验
  • ELISA 检测
• 其他免疫诊断技术
• 分子诊断
  • 聚合酵素链锁反应（PCR）检测
  • 微阵列
• 其他分子诊断测试
• 其他兽医诊断技术

动物感染疾病诊断市场规模（按动物类型和复合年增长率）（2025-2032）

• 市场概况
• 伴同性动物
  • 狗
  • 猫
  • 马
• 其他宠物
• 食用动物
  • 牛
  • 猪
  • 家禽
  • 其他食用动物

动物感染疾病诊断市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 参考实验室
• 兽医研究机构和诊所
• 照护现场和内部测试
• 科学研究机构/大学

动物感染疾病诊断市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• IDEXX Laboratories, Inc.（US）
• Zoetis, Inc.（US）
• Thermo Fisher Scientific, Inc.（US）
• Virbac（France）
• bioMerieux SA（France）
• Heska Corporation（US）
• NEOGEN Corporation（US）
• QIAGEN NV（Netherlands）
• Randox Laboratories Ltd.（UK）
• Agrolabo S.pA.（Italy）
• Bio-Rad Laboratories（US）
• Bionote, Inc.（South Korea）
• Biogal Galed Labs（Israel）
• BioChek（Netherlands）
• Biopanda Reagents（UK）
• URIT Medical Electric Co. Ltd.（China）
• MEGACOR Diagnostik GmbH（Germany）
• Fassisi GmbH（Germany）
• Alvedia（France）
• SKYER, Inc.（South Korea）

结论和建议

Veterinary Infectious Disease Diagnostics Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.18 billion in 2024 to USD 4.34 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The veterinary infectious disease diagnostics market is essential for the prompt and accurate identification of infectious diseases in animals, leading to enhanced health outcomes and improved disease control. Rising instances of animal infectious diseases, influenced by globalization, climate change, and evolving husbandry practices, are fueling market growth. However, challenges like high diagnostic costs, limited accessibility in developing regions, and a shortage of skilled professionals may hinder its expansion. Continuous R&D is crucial to develop sensitive and specific diagnostic tools. Despite these barriers, opportunities abound through technological innovations, such as rapid and point-of-care tests. Increased awareness of zoonotic diseases and the One Health paradigm further propels this market, solidifying its critical role in global animal and public health management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Infectious Disease Diagnostics Market Segments Analysis

Global Veterinary Infectious Disease Diagnostics Market is segmented by Infection Type, Technology, Animal Type, End User and Region. Based on Infection Type, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Infections and Other Infections. Based on Technology, the market is segmented into Immunodiagnostics, Other immunodiagnostic technologies, Molecular Diagnostics, Other molecular diagnostic tests and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals, Other companion animals and Food Producing Animals. Based on End User, the market is segmented into Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing and Research Institutes and Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Veterinary Infectious Disease Diagnostics Market

The veterinary infectious disease diagnostics market is witnessing significant growth driven by heightened awareness of animal health and welfare among pet owners and livestock producers. There is a burgeoning demand for sophisticated diagnostic tools and services that facilitate the early detection and effective management of infectious diseases. The COVID-19 pandemic in 2022 underscored the critical need for monitoring animal health and establishing strong diagnostic systems to identify potential zoonotic diseases, further emphasizing the importance of investing in advanced veterinary diagnostics. This increased focus on animal welfare and disease prevention has propelled the market forward, creating a need for innovative solutions in this sector.

Restraints in the Veterinary Infectious Disease Diagnostics Market

One major constraint in the veterinary infectious disease diagnostics market is the high expense linked to advanced diagnostic technologies and services. Implementing state-of-the-art diagnostic tools often demands considerable financial investment, which can be particularly challenging for small veterinary practices or those situated in financially limited areas. This financial barrier may restrict the accessibility and application of sophisticated diagnostic techniques, ultimately restraining the overall growth of the market. As a result, the disparity in resources can lead to uneven adoption rates of these innovative technologies, impacting the efficiency of disease diagnosis and management in the veterinary field.

Market Trends of the Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics market is increasingly influenced by the growing adoption of point-of-care testing (POCT), which has emerged as a pivotal trend. With the shift towards rapid, on-site diagnostic capabilities, veterinarians can now obtain real-time results without relying on centralized laboratories, thereby enhancing immediate decision-making and operational efficiency. This trend has accelerated since 2022, driven by advancements in portable and user-friendly POCT devices tailored for infectious disease diagnosis in animals. As the demand for timely and accurate diagnostics rises, the market is poised for significant growth, reflecting a broader commitment to improving animal health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Infectious Disease Diagnostics Market Size by Infection Type & CAGR (2025-2032)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Other Infections

Global Veterinary Infectious Disease Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Immunodiagnostics
  • Lateral flow assays
  • ELISA tests
• Other immunodiagnostic technologies
• Molecular Diagnostics
  • Polymerase chain reaction (PCR) tests
  • Microarrays
• Other molecular diagnostic tests
• Other Veterinary Diagnostic Technologies

Global Veterinary Infectious Disease Diagnostics Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
• Other companion animals
• Food Producing Animals
  • Cattle
  • Swine
  • Poultry
  • Other food-producing animals

Global Veterinary Infectious Disease Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In House Testing
• Research Institutes and Universities

Global Veterinary Infectious Disease Diagnostics Market Size & CAGR (2025-2032)

• North America (Infection Type, Technology, Animal Type, End User)
  • US
  • Canada
• Europe (Infection Type, Technology, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Infection Type, Technology, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Infection Type, Technology, Animal Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Infection Type, Technology, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IDEXX Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.pA. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electric Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGACOR Diagnostik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SKYER, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations